• "Malaria Breakthrough: New Vaccines and Continued Challenges"

  • Dec 25 2024
  • Length: 3 mins
  • Podcast

"Malaria Breakthrough: New Vaccines and Continued Challenges"

Listen for free

View show details

  • Summary

  • In the ongoing fight against malaria, several significant developments have emerged recently, highlighting both progress and the need for continued efforts.

    The World Health Organization’s (WHO) 2024 World Malaria Report, released earlier this month, reflects on nearly a quarter-century of progress in combating the disease. Thanks to U.S. leadership and global partnerships, 2.2 billion cases of malaria have been averted, 12.7 million lives have been saved, and 44 countries have eliminated the disease. A key component of this success is the introduction of the world’s first-ever malaria vaccines into routine childhood immunization programs in 17 countries, with more set to follow. Last year, 195 million next-generation insecticide-treated nets were distributed, further bolstering malaria control efforts[1].

    A major breakthrough in malaria vaccine development has been announced by researchers at the University of Oxford. They have unveiled the first vaccine targeting the blood-stage of malaria, which has shown promising safety and efficacy in early trials. The vaccine, RH5.1/Matrix-M™, was tested in a clinical trial involving 360 children in Burkina Faso and demonstrated 55% efficacy in preventing clinical malaria and over 80% efficacy in preventing severe cases. This development complements existing liver-stage malaria vaccines and offers a vital second line of defense against the disease[2].

    The current malaria vaccines, including the R21/Matrix-M vaccine, have been recommended by the WHO for use in children living in moderate to high malaria transmission areas. These vaccines reduce uncomplicated malaria by around 40%, severe malaria by 30%, and all-cause mortality by 13%. The R21/Matrix-M vaccine has been particularly noted for its safety, cost-effectiveness, and high efficacy in highly seasonal malaria settings. Countries like the Central African Republic have introduced this vaccine into their routine immunization programs, aiming to vaccinate around 200,000 children in 2024[3][5].

    Despite these advancements, challenges persist. Partial resistance to a life-saving antimalarial drug has been detected in Uganda among children with severe forms of the disease, underscoring the need for continued vigilance and innovation. Additionally, increasing malaria surges in Ethiopia threaten to undo the progress made over the past two decades, prompting the Ethiopian government to launch a comprehensive approach to combat these outbreaks[4].

    In conclusion, the recent news highlights significant strides in malaria control, particularly through vaccine development and distribution. However, it also emphasizes the ongoing need for accelerated, data-driven action to address emerging challenges and ensure continued progress in the fight against malaria.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about "Malaria Breakthrough: New Vaccines and Continued Challenges"

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available